Your browser doesn't support javascript.
loading
Demethyleneberberine alleviated the inflammatory response by targeting MD-2 to inhibit the TLR4 signaling.
Zhao, Yaxing; Liu, Peng; Luan, Haofan; Jiang, Hua; Xu, Yingmei; Zhang, Yuanqiang; Zhang, Yubin; Li, Ruiyan.
Afiliación
  • Zhao Y; State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing, China.
  • Liu P; Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Luan H; Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Pharmaceutical Sciences, Jiangnan University, Wuxi, China.
  • Jiang H; State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing, China.
  • Xu Y; State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing, China.
  • Zhang Y; State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing, China.
  • Zhang Y; State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing, China.
  • Li R; State Key Laboratory of Natural Medicines, Department of Biochemistry, China Pharmaceutical University, Nanjing, China.
Front Immunol ; 14: 1130404, 2023.
Article en En | MEDLINE | ID: mdl-37168866
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis / Receptor Toll-Like 4 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis / Receptor Toll-Like 4 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza